A Synthetic Cytokine Receptor Platform for Producing Cytotoxic Innate Lymphocytes as Off-the-Shelf Cancer Therapeutics Dan A Synthetic Cytokine Receptor Platform for Producing Cytotoxic Innate Lymphocytes as Off-the-Shelf Cancer Therapeutics Read More »
Development of a Scalable, Suspension Cell Culture-Based Manufacturing Process for VivoVec, A Lentiviral Vector Platform for In Vivo CAR T-Cell Generation Dan Development of a Scalable, Suspension Cell Culture-Based Manufacturing Process for VivoVec, A Lentiviral Vector Platform for In Vivo CAR T-Cell Generation Read More »
VivoVec: A novel lentiviral-based in vivo CAR T cell generation platform with viral particlesurface engineering incorporating T cell activating and co-stimulatory ligands Dan VivoVec: A novel lentiviral-based in vivo CAR T cell generation platform with viral particlesurface engineering incorporating T cell activating and co-stimulatory ligands Read More »
A synthetic cytokine receptor platform for producing cytotoxic innate lymphocytes as “off-the-shelf” cancer therapeutics John Policano A synthetic cytokine receptor platform for producing cytotoxic innate lymphocytes as “off-the-shelf” cancer therapeutics Read More »
Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeutics. Dan Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeutics. Read More »
